March 10, 2021
Using Both, Immunotherapy and Chemotherapy Doubles Lung Cancer Survival
Research shows using both immunotherapy and chemotherapy for treatment doubles survival among those diagnosed with lung cancer.
WebMD
Research News
Latest Advances in Lung Cancer Research
Explore our curated selection of the latest breakthroughs in lung cancer research.
-
-
March 10, 2021
KRAS Mutation sees Promise for New Therapies
KRAS mutation, previously seen as “undruggable” sees promise for new therapies through improbable targets for lung cancer.
Medical Xpress
-
March 2, 2021
Merck Pulls Keytruda for SCLC
Merck pulls Keytruda for SCLC. Pharmaceutical company, Merck announced plans to pull Ketruda for SCLC due to disappointing results from Phase III trial.
Biospace
Get the latest lung cancer research news directly in your inbox.
Learn more about:
- the latest science in lung cancer
- stories about living with lung cancer
- how LCFA is working to fund more lung cancer research grants
LCFA prioritizes providing reliable information about new diagnostics, treatments, and prevention strategies, including exciting FDA-approved personalized therapies based on individual tumor biomarkers. Human-reviewed, AI-created content is used to create some of the summaries for the articles listed.